OA13033A - Attenuated strains of Vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination. - Google Patents

Attenuated strains of Vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination. Download PDF

Info

Publication number
OA13033A
OA13033A OA1200500234A OA1200500234A OA13033A OA 13033 A OA13033 A OA 13033A OA 1200500234 A OA1200500234 A OA 1200500234A OA 1200500234 A OA1200500234 A OA 1200500234A OA 13033 A OA13033 A OA 13033A
Authority
OA
OAPI
Prior art keywords
strains
phage
vibrio cholerae
vgj
lmg
Prior art date
Application number
OA1200500234A
Other languages
English (en)
Inventor
Gomez Javier Campos
Rodriguez Herminia Delgado
Calzada Rafael Alfredo Fando
Perez Talena Yamile Ledon
Dominguez Karen Marrero
Gutierrez Eriel Martinez
Hernandez Tomas Marcelino Moreira
Gonzalez Boris Luis Rodriguez
Larranaga Yussuan Silva
Portal Edith Suzarte
Villa Vicencio Caridad Urra
Original Assignee
Ct Nat De Investigaciones Cientificas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CU20030039A external-priority patent/CU23209A1/es
Priority claimed from CU20030084A external-priority patent/CU23206A1/es
Application filed by Ct Nat De Investigaciones Cientificas filed Critical Ct Nat De Investigaciones Cientificas
Publication of OA13033A publication Critical patent/OA13033A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
OA1200500234A 2003-02-20 2004-02-19 Attenuated strains of Vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination. OA13033A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20030039A CU23209A1 (es) 2003-02-20 2003-02-20 Candidatos vacunales vivos con indices mejorados de seguridad ambiental para inmunizar oralmente contra el colera
CU20030084A CU23206A1 (es) 2003-04-17 2003-04-17 Formulaciones para liofilizacion de vacunas vivas atenuadas de vibrio cholerae mejoradas en su seguridad ambiental

Publications (1)

Publication Number Publication Date
OA13033A true OA13033A (en) 2006-11-10

Family

ID=40203010

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200500234A OA13033A (en) 2003-02-20 2004-02-19 Attenuated strains of Vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination.

Country Status (16)

Country Link
US (1) US7592171B2 (es)
EP (1) EP1614426B1 (es)
JP (1) JP4495143B2 (es)
CN (1) CN100569286C (es)
AP (1) AP1724A (es)
AT (1) ATE417625T1 (es)
BR (1) BRPI0407668A (es)
CA (1) CA2516581C (es)
DE (1) DE602004018478D1 (es)
DK (1) DK1614426T3 (es)
EC (1) ECSP055971A (es)
ES (1) ES2319527T3 (es)
MX (1) MXPA05008774A (es)
OA (1) OA13033A (es)
RU (1) RU2316587C2 (es)
WO (1) WO2004073736A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325494D0 (en) * 2003-10-31 2003-12-03 Sbl Vaccin Ab Expression system
US20060233837A1 (en) * 2005-04-19 2006-10-19 Gomez Javier C Vibrio cholerae vaccine candidates, the methods of their constructing and medicinal preparations derived thereof
WO2008143782A1 (en) * 2007-05-18 2008-11-27 Medimmune, Llc Preservation of bioactive materials by freeze dried foam
CN101880640B (zh) * 2010-02-09 2013-05-29 北京万特尔生物制药有限公司 肺炎克雷伯氏菌(甘露糖敏感血凝)菌毛株
CN101914463B (zh) * 2010-02-09 2012-09-05 北京万特尔生物制药有限公司 普通变形菌(甘露糖敏感血凝)菌毛株
CU24188B1 (es) * 2012-12-27 2016-07-29 Ct De Ingeniería Genética Y Biotecnología Composición vacunal contra el virus dengue
WO2016113322A1 (en) * 2015-01-14 2016-07-21 Centre National De La Recherche Scientifique Genetically modified vibrio cholerae strains and uses thereof
CN111511394B (zh) * 2017-07-12 2024-02-06 布里格姆妇女医院 具有益生菌特性的活减毒霍乱疫苗
CN110184241B (zh) * 2019-05-14 2021-01-26 菲吉乐科(南京)生物科技有限公司 耐高温溶藻弧菌噬菌体及其组合物、试剂盒和应用
CN111004759B (zh) * 2020-01-04 2023-04-07 广东环凯生物科技有限公司 一种霍乱弧菌的稳定剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3916304B2 (ja) * 1997-07-25 2007-05-16 三菱レイヨン株式会社 屈折率分布型光ファイバ
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
CU22847A1 (es) * 1998-10-22 2003-04-28 Cnic Ct Nac Investigaciones Conservación de formulaciones vacunales de vibrio cholerae

Also Published As

Publication number Publication date
RU2005125793A (ru) 2006-05-27
CN1780640A (zh) 2006-05-31
JP2006518196A (ja) 2006-08-10
DK1614426T3 (da) 2009-04-06
CN100569286C (zh) 2009-12-16
CA2516581C (en) 2012-05-15
JP4495143B2 (ja) 2010-06-30
BRPI0407668A (pt) 2006-03-01
ECSP055971A (es) 2006-01-16
AP2005003378A0 (en) 2005-09-30
WO2004073736A1 (es) 2004-09-02
US7592171B2 (en) 2009-09-22
DE602004018478D1 (de) 2009-01-29
AP1724A (en) 2007-02-23
EP1614426A1 (en) 2006-01-11
ATE417625T1 (de) 2009-01-15
MXPA05008774A (es) 2006-02-22
EP1614426B1 (en) 2008-12-17
US20070071775A1 (en) 2007-03-29
RU2316587C2 (ru) 2008-02-10
WO2004073736A8 (es) 2005-11-17
ES2319527T3 (es) 2009-05-08
CA2516581A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
JP4179627B2 (ja) コレラワクチンとしての欠失変異体
Noriega et al. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine
Bik et al. Genetic organization and functional analysis of the otn DNA essential for cell‐wall polysaccharide synthesis in Vibrio cholerae O139
JPH09500538A (ja) ナイセリア・メニンギチジス外膜グループｂポーリンタンパク質の高レベル発現、精製および再生
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
US8709813B2 (en) DNA promoters and anthrax vaccines
JP6329544B2 (ja) 新規生弱毒化赤痢菌属（Ｓｈｉｇｅｌｌａ）ワクチン
CA2516581C (en) Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
ZA200507021B (en) Attenuated strains of Vibrio cholerae and lyophilised vaccines containing same
EP0358692B1 (en) Cholera vaccines
CA2298063A1 (fr) Souches de mycobacterium dont le gene erp est modifie et composition vaccinale la contenant
US20060008477A1 (en) Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins
US20060233837A1 (en) Vibrio cholerae vaccine candidates, the methods of their constructing and medicinal preparations derived thereof
Cloud Lytic transglycosylases are responsible for the production of peptidoglycan-derived cytotoxin in Neisseria gonorrhoeae
Ludu Characterization of PdpD, a Francisella pathogenicity island protein.